CDKN2A and neoplasm: ‘In mouse models of leukemia and melanoma, IDH mutants accelerated cell cycle transition by activation of the MAPK and ERK pathway and repression of tumor suppressors CDKN2A and CDKN2B (Chaturvedi et al., Shibata et al.)’